首页 > 最新文献

Journal of Experimental Therapeutics and Oncology最新文献

英文 中文
Oral focal mucinosis in adolesence: a sparingly diagnosed clinicopathologic entity. 青少年口腔局灶性黏液病:一种极少被诊断的临床病理实体。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01
Samreen Taufiq, Madhusudan Astekar, Sowmya Gv, Manjunatha Bs, Shipra Saxena

Objective: Oral focal mucinosis an oral counterpart of cutaneous focal mucinosis, is a rare disease of unknown etiology. Its pathogenesis may be due to the overproduction of hyaluronic acid by a fibroblast, at the expense of collagen production, resulting in focal myxoid degeneration of the connective tissue, primarily affecting the mucosa overlying the bone. Oral focal mucinosis occurs predonderantly in adults during the fourth and fifth decade of life, although it has been reported sparingly in children and adolescents. It has no distinctive clinical features, as the diagnosis is solely based on the histopathological features and treatment involves complete surgical excision. Recurrence is unreported. This case report put forward the clinical and histological presentation and consequent management of Oral focal mucinosis in an adolescent female patient.

目的:口腔局灶性黏液病是一种病因不明的罕见疾病,与皮肤局灶性黏液病相对应。其发病机制可能是由于成纤维细胞产生过多的透明质酸,以牺牲胶原蛋白的产生为代价,导致结缔组织的局灶性粘液样变性,主要影响骨上覆盖的粘膜。口腔局灶性黏液病主要发生在40岁和50岁的成年人中,尽管在儿童和青少年中也有少量报道。它没有明显的临床特征,因为诊断完全基于组织病理学特征,治疗涉及完全手术切除。复发未见报道。本病例报告提出了一名青少年女性口腔局灶性黏液病的临床和组织学表现及相应的治疗。
{"title":"Oral focal mucinosis in adolesence: a sparingly diagnosed clinicopathologic entity.","authors":"Samreen Taufiq,&nbsp;Madhusudan Astekar,&nbsp;Sowmya Gv,&nbsp;Manjunatha Bs,&nbsp;Shipra Saxena","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Oral focal mucinosis an oral counterpart of cutaneous focal mucinosis, is a rare disease of unknown etiology. Its pathogenesis may be due to the overproduction of hyaluronic acid by a fibroblast, at the expense of collagen production, resulting in focal myxoid degeneration of the connective tissue, primarily affecting the mucosa overlying the bone. Oral focal mucinosis occurs predonderantly in adults during the fourth and fifth decade of life, although it has been reported sparingly in children and adolescents. It has no distinctive clinical features, as the diagnosis is solely based on the histopathological features and treatment involves complete surgical excision. Recurrence is unreported. This case report put forward the clinical and histological presentation and consequent management of Oral focal mucinosis in an adolescent female patient.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36876608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controlling the growth rate of cancer cell. 控制癌细胞的生长速度。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01
Sunil Kumar Kashyap, Swati Jain, A Satheesh, B R Manju, Vikas Kumar Jain

Objective: To control the rate of growth of the cancer cell is the objective of this paper. In cancer, the rate of the growth of the cancer cell is indefinite. This paper proposes a method to transform into definite rate of growth of the cancer cell from indefinite. This indefiniteness lies with the set of unknown elements. This paper finds these unknown elements by matrix method.

目的:控制肿瘤细胞的生长速度是本研究的目的。在癌症中,癌细胞的生长速度是不确定的。本文提出了一种将癌细胞生长速度由不确定转化为确定的方法。这种不确定性在于未知元素的集合。本文用矩阵法求出这些未知元素。
{"title":"Controlling the growth rate of cancer cell.","authors":"Sunil Kumar Kashyap,&nbsp;Swati Jain,&nbsp;A Satheesh,&nbsp;B R Manju,&nbsp;Vikas Kumar Jain","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To control the rate of growth of the cancer cell is the objective of this paper. In cancer, the rate of the growth of the cancer cell is indefinite. This paper proposes a method to transform into definite rate of growth of the cancer cell from indefinite. This indefiniteness lies with the set of unknown elements. This paper finds these unknown elements by matrix method.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36866456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Convolutions of dentigerous cyst: An institutional experience. 含牙囊肿的卷曲:一个机构的经验。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-01-01
Vanshika Makkar, Mala Kamboj, Anjali Narwal

Objective: Statement of the Problem: Benign appearing dentigerous cyst (DC), also the most common developmental odontogenic cyst, shows various complications due to its pluripotent cell lining. The spectrum of diseases produced by conversion of its pluripotent cell varies from unicystic ameloblastoma, intraosseous epidermoid and central mucoepidermoid carcinoma. So, the need of the hour is to be acquainted with the etiopathogenesis of DC at molecular level and an attempt should be made to minimize its rate of tumor conversion.

Purpose: To analyze the potential complications, their demographic profile, disease characteristics which can arise from the dentigerous cyst, and to be geared up for such situations in future.

Materials and method: Retrospective analysis was conducted and data was collected from the requisition forms during the time frame 2011- 2016 in the Department at Government Dental College, Haryana. Histopathologically diagnosed cases of dentigerous cyst were reviewed by three different observers and recorded, out of which DCs that showed potential complications were reviewed in detail.

Results: Six cases of DC out of 26 showed transformation into central mucoepidermoid carcinoma, adenomatoid odontogenic tumor (two) and ameloblastoma (three) respectively.

Conclusion: The present research highlights the probable complications of DC encountered in our institute and conscientious vigilance should be exercised while histopathological examination of biopsied specimens. This study further unravels the enigma behind the emergence of neoplasms arising from DC.

目的:问题陈述:良性牙性囊肿(DC),也是最常见的发育性牙源性囊肿,由于其多能性细胞衬里而表现出各种并发症。由其多能细胞转化而产生的疾病包括单囊性成釉细胞瘤、骨内表皮样癌和中央黏液表皮样癌。因此,当务之急是在分子水平上了解DC的发病机制,并努力使其肿瘤转化率降到最低。目的:分析含牙囊肿可能引起的并发症、人口学特征、疾病特征,为今后此类情况做好准备。材料和方法:回顾性分析并收集哈里亚纳邦政府牙科学院2011- 2016年期间的申请单数据。由三名不同的观察员回顾并记录了组织病理学诊断的含牙囊肿病例,其中详细回顾了显示潜在并发症的dc。结果:26例DC中分别有6例转化为中枢性黏液表皮样癌、腺瘤样牙源性肿瘤和成釉细胞瘤。结论:本研究突出了本院DC可能的并发症,在对活检标本进行组织病理学检查时应提高警惕。这项研究进一步揭开了DC引起的肿瘤出现背后的谜团。
{"title":"Convolutions of dentigerous cyst: An institutional experience.","authors":"Vanshika Makkar,&nbsp;Mala Kamboj,&nbsp;Anjali Narwal","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Statement of the Problem: Benign appearing dentigerous cyst (DC), also the most common developmental odontogenic cyst, shows various complications due to its pluripotent cell lining. The spectrum of diseases produced by conversion of its pluripotent cell varies from unicystic ameloblastoma, intraosseous epidermoid and central mucoepidermoid carcinoma. So, the need of the hour is to be acquainted with the etiopathogenesis of DC at molecular level and an attempt should be made to minimize its rate of tumor conversion.</p><p><strong>Purpose: </strong>To analyze the potential complications, their demographic profile, disease characteristics which can arise from the dentigerous cyst, and to be geared up for such situations in future.</p><p><strong>Materials and method: </strong>Retrospective analysis was conducted and data was collected from the requisition forms during the time frame 2011- 2016 in the Department at Government Dental College, Haryana. Histopathologically diagnosed cases of dentigerous cyst were reviewed by three different observers and recorded, out of which DCs that showed potential complications were reviewed in detail.</p><p><strong>Results: </strong>Six cases of DC out of 26 showed transformation into central mucoepidermoid carcinoma, adenomatoid odontogenic tumor (two) and ameloblastoma (three) respectively.</p><p><strong>Conclusion: </strong>The present research highlights the probable complications of DC encountered in our institute and conscientious vigilance should be exercised while histopathological examination of biopsied specimens. This study further unravels the enigma behind the emergence of neoplasms arising from DC.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36866454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of oral squamous cell carcinoma in Bareilly Region: A seven year institutional study. 巴雷利地区口腔鳞状细胞癌患病率:一项为期七年的机构研究。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2018-11-01
Madhusudan Astekar, Samreen Taufiq, Gaurav Sapra, Ashutosh Agarwal, Aditi Murari, Harshita Putthia

Background: Oral squamous cell carcinoma is a major contributor to disability and death caused by malignant tumors. Variations in social, cultural, and geographic factors affect the tumor behavior and response to treatment. In this study, we undertake a seven years institutional review and analysis of Oral squamous cell carcinoma cases in Bareilly.

Materials and methods: A total of 1938 histologically diagnosed cases during the period of seven years i.e. from 2010 to 2016 were extracted from the archives of Department of Oral & Maxillofacial Pathology, Institute of Dental Sciences, Bareilly and evaluated to know the prevalence of Oral squamous cell carcinoma. The details like age, sex, habits and anatomical site were also recorded from the archived patient's case sheets.

Results: Out of the total 1938 cases, 318 were found to be Oral squamous cell carcinoma of which 232 were males and 86 were females. Incidence was highest in 40-49 year age group. The most common site was buccal mucosa (190 cases), followed by tongue (68 cases). Most lesions were well differentiated Oral squamous cell carcinoma (230 cases). Patients with poorly differentiated lesions had a comparatively lower mean age than their counterparts with other histological varieties.

Conclusion: The pattern of Oral squamous cell carcinoma differs from that of previous studies in relation to incidence and age correlation with the grade of carcinoma. The majority of the lesions were well differentiated. There is a need for intensive oral health awareness to encourage early presentation to cancer center as early detection will further enhance prognosis.

背景:口腔鳞状细胞癌是恶性肿瘤致残和死亡的主要原因。不同的社会、文化和地理因素会影响肿瘤的行为和对治疗的反应。在这项研究中,我们进行了7年的机构回顾和分析口腔鳞状细胞癌病例在巴雷利。材料与方法:选取巴雷利口腔科学研究所口腔颌面病理科档案中2010 - 2016年7年间组织学诊断病例1938例,进行评估,了解口腔鳞状细胞癌的患病率。年龄、性别、习惯和解剖部位等细节也从存档的患者病例表中记录下来。结果:1938例口腔鳞癌318例,其中男性232例,女性86例。发病率以40 ~ 49岁年龄组最高。最常见部位为颊黏膜(190例),其次为舌部(68例)。病变多为高分化口腔鳞状细胞癌(230例)。低分化病变患者的平均年龄相对低于其他组织学类型的患者。结论:口腔鳞状细胞癌的类型与以往的研究不同,发病率和年龄与癌的分级相关。多数病变分化良好。有必要加强口腔健康意识,鼓励早期到癌症中心就诊,因为早期发现将进一步提高预后。
{"title":"Prevalence of oral squamous cell carcinoma in Bareilly Region: A seven year institutional study.","authors":"Madhusudan Astekar,&nbsp;Samreen Taufiq,&nbsp;Gaurav Sapra,&nbsp;Ashutosh Agarwal,&nbsp;Aditi Murari,&nbsp;Harshita Putthia","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Oral squamous cell carcinoma is a major contributor to disability and death caused by malignant tumors. Variations in social, cultural, and geographic factors affect the tumor behavior and response to treatment. In this study, we undertake a seven years institutional review and analysis of Oral squamous cell carcinoma cases in Bareilly.</p><p><strong>Materials and methods: </strong>A total of 1938 histologically diagnosed cases during the period of seven years i.e. from 2010 to 2016 were extracted from the archives of Department of Oral & Maxillofacial Pathology, Institute of Dental Sciences, Bareilly and evaluated to know the prevalence of Oral squamous cell carcinoma. The details like age, sex, habits and anatomical site were also recorded from the archived patient's case sheets.</p><p><strong>Results: </strong>Out of the total 1938 cases, 318 were found to be Oral squamous cell carcinoma of which 232 were males and 86 were females. Incidence was highest in 40-49 year age group. The most common site was buccal mucosa (190 cases), followed by tongue (68 cases). Most lesions were well differentiated Oral squamous cell carcinoma (230 cases). Patients with poorly differentiated lesions had a comparatively lower mean age than their counterparts with other histological varieties.</p><p><strong>Conclusion: </strong>The pattern of Oral squamous cell carcinoma differs from that of previous studies in relation to incidence and age correlation with the grade of carcinoma. The majority of the lesions were well differentiated. There is a need for intensive oral health awareness to encourage early presentation to cancer center as early detection will further enhance prognosis.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36765395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A direction to prepare the cancer vaccine. 一个制备癌症疫苗的方向。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2018-11-01
Sunil Kumar Kashyap, Vikas Kumar Jain, Swati Jain, Ashutosh Pandey

Objective: The vaccine of the cancer can be prepared. This paper presents a direction for preparing the vaccine of cancer by algebraic and geometric study of the cancer cell.

目的:制备肿瘤疫苗。本文通过对癌细胞的代数和几何研究,提出了制备肿瘤疫苗的方向。
{"title":"A direction to prepare the cancer vaccine.","authors":"Sunil Kumar Kashyap,&nbsp;Vikas Kumar Jain,&nbsp;Swati Jain,&nbsp;Ashutosh Pandey","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The vaccine of the cancer can be prepared. This paper presents a direction for preparing the vaccine of cancer by algebraic and geometric study of the cancer cell.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36765396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basal cell ameloblastoma: a rare entity expressed in a middle aged female. 基底细胞成釉细胞瘤:在中年女性中表达的罕见实体。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2018-11-01
Rajesh Kumar, Aanchal Sharma, Hussain Sabir

Objective: Ameloblastoma is a true neoplasm of enamel organ type tissue which does not undergo differentiation to the point of enamel formation. It is a benign, locally invasive tumour of the oral cavity, most commonly affecting the maxilla and the mandible. Histologically there are several variants of ameloblastoma, the basal cell type being the least reported one. In this paper, we are presenting a case of basal cell ameloblastoma of the mandible with a brief review of literature.

目的:成釉细胞瘤是一种未分化到牙釉质形成的真正的牙釉质器官型组织肿瘤。它是一种良性的口腔局部浸润性肿瘤,最常影响上颌骨和下颌骨。组织学上有几种成釉细胞瘤,基底细胞型是报道最少的一种。在本文中,我们提出了一个病例基底细胞成釉细胞瘤的下颌骨,并简要回顾文献。
{"title":"Basal cell ameloblastoma: a rare entity expressed in a middle aged female.","authors":"Rajesh Kumar,&nbsp;Aanchal Sharma,&nbsp;Hussain Sabir","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Ameloblastoma is a true neoplasm of enamel organ type tissue which does not undergo differentiation to the point of enamel formation. It is a benign, locally invasive tumour of the oral cavity, most commonly affecting the maxilla and the mandible. Histologically there are several variants of ameloblastoma, the basal cell type being the least reported one. In this paper, we are presenting a case of basal cell ameloblastoma of the mandible with a brief review of literature.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36715860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimation of serum beta-carotene level in patients suffering from oral submucous fibrosis. 口腔黏膜下纤维化患者血清β -胡萝卜素水平的评估。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2018-11-01
Yogesh G Rathod, Sunita P Kulkarni, Mahesh R Khairnar, Purushottam N Joshi, Bhaskar K Patle, Jaishree S Pagare

Introduction: Oral submucous fibrosis (OSMF), an insidious disease, has not been widely studied with respect to levels of serum beta-carotene (b-carotene). Hence present study aimed to estimate level of serum beta carotene in patients with OSMF.

Material and methods: 40 subjects (study subjects) with different grades of OSMF and 40 apparently healthy subjects without OSMF (control subjects with age and sex matched as that of study subjects) were screened for serum b-carotene levels employing Sobel and Snow's method. Subjects in both the groups had areca nut or gutkha chewing habit.

Results: Study subjects with OSMF showed lower levels of serum b-carotene as compared to control group subjects without OSMF. When the levels were compared between different disease stages, least levels of serum b-carotene were seen in Grade III OSMF subjects, as compared with Grade I and II subjects. Females showed higher levels of serum b-carotene than males in both the groups. Smokers showed depleted levels as compared to non-smokers in both groups.

Conclusion: b-carotene plays an important role in the pathogenesis of OSMF, and its level decreases with disease progression.

口腔黏膜下纤维化(OSMF)是一种隐匿性疾病,其与血清β -胡萝卜素(b-胡萝卜素)水平的关系尚未得到广泛研究。因此,本研究旨在评估OSMF患者血清β -胡萝卜素水平。材料与方法:采用Sobel和Snow方法筛选40名不同程度OSMF的受试者(研究对象)和40名年龄、性别与研究对象匹配的明显健康无OSMF的对照受试者(对照组)血清b-胡萝卜素水平。两组受试者都有嚼槟榔或槟榔的习惯。结果:与没有OSMF的对照组相比,有OSMF的研究对象的血清b-胡萝卜素水平较低。当比较不同疾病阶段之间的水平时,与I级和II级受试者相比,III级OSMF受试者的血清b-胡萝卜素水平最低。在两组中,女性的血清b-胡萝卜素水平都高于男性。与不吸烟者相比,吸烟者在两组中都表现出较低的水平。结论:b-胡萝卜素在OSMF发病过程中起重要作用,其水平随病情进展而降低。
{"title":"Estimation of serum beta-carotene level in patients suffering from oral submucous fibrosis.","authors":"Yogesh G Rathod,&nbsp;Sunita P Kulkarni,&nbsp;Mahesh R Khairnar,&nbsp;Purushottam N Joshi,&nbsp;Bhaskar K Patle,&nbsp;Jaishree S Pagare","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Oral submucous fibrosis (OSMF), an insidious disease, has not been widely studied with respect to levels of serum beta-carotene (b-carotene). Hence present study aimed to estimate level of serum beta carotene in patients with OSMF.</p><p><strong>Material and methods: </strong>40 subjects (study subjects) with different grades of OSMF and 40 apparently healthy subjects without OSMF (control subjects with age and sex matched as that of study subjects) were screened for serum b-carotene levels employing Sobel and Snow's method. Subjects in both the groups had areca nut or gutkha chewing habit.</p><p><strong>Results: </strong>Study subjects with OSMF showed lower levels of serum b-carotene as compared to control group subjects without OSMF. When the levels were compared between different disease stages, least levels of serum b-carotene were seen in Grade III OSMF subjects, as compared with Grade I and II subjects. Females showed higher levels of serum b-carotene than males in both the groups. Smokers showed depleted levels as compared to non-smokers in both groups.</p><p><strong>Conclusion: </strong>b-carotene plays an important role in the pathogenesis of OSMF, and its level decreases with disease progression.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36715966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The potential of less radical surgery without parametrectomy. Are we safe? 不切除参数的非根治性手术的潜力。我们安全吗?
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2018-11-01
Konstantinos Ntzeros, Nikolaos Thomakos, Ioannis Papapanagiotou, Alexandros Rodolakis

Aim: The aim of this study is to evaluate whether omission of parametrial removal in low risk patients with early stage cervical cancer is safe, taking into account the favorable prognostic characteristics that are usually used in recent studies debating a more conservative treatment in such patients.

Methods: A comprehensive search conducted in PubMed and MEDLINE databases.

Results: In low risk patients with favorable prognostic factors such as tumor size ≤2 cm, depth of stromal invasion ≤10 mm and no LVSI, there are 5% of patients having positive pelvic lymph nodes. Although parametrial involvement is associated with positive pelvic lymph node metastasis, there are studies which report patients with negative pelvic lymph node involvement with parametrial metastases. This indicates that although negative pelvic lymph nodes in low risk patients is a favorable criterion among of those previously reported for conservative treatment, does not eliminate the possibility of parametrial involvement.

Conclusions: Although specific favorable prognostic characteristics may indicate less radical treatment for low risk patients with early stage cervical cancer, more research is needed to estimate the risk of parametrial involvement in low risk patients without pelvic node involvement.

目的:本研究的目的是评估低风险早期宫颈癌患者省略参数切除是否安全,考虑到近期研究中通常使用的有利预后特征,这些特征在这类患者中争论更保守的治疗。方法:在PubMed和MEDLINE数据库中进行综合检索。结果:在肿瘤大小≤2 cm、间质浸润深度≤10 mm、无LVSI等预后有利因素的低危患者中,有5%的患者盆腔淋巴结阳性。虽然参数淋巴结受累与盆腔淋巴结转移阳性相关,但也有研究报道盆腔淋巴结受累阴性的患者存在参数淋巴结转移。这表明,尽管在先前报道的保守治疗中,低风险患者盆腔淋巴结阴性是一个有利的标准,但并不能消除参数性受累的可能性。结论:尽管特定的良好预后特征可能表明低风险早期宫颈癌患者的根治性治疗较少,但需要更多的研究来评估无盆腔淋巴结累及的低风险患者的参数累及风险。
{"title":"The potential of less radical surgery without parametrectomy. Are we safe?","authors":"Konstantinos Ntzeros,&nbsp;Nikolaos Thomakos,&nbsp;Ioannis Papapanagiotou,&nbsp;Alexandros Rodolakis","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study is to evaluate whether omission of parametrial removal in low risk patients with early stage cervical cancer is safe, taking into account the favorable prognostic characteristics that are usually used in recent studies debating a more conservative treatment in such patients.</p><p><strong>Methods: </strong>A comprehensive search conducted in PubMed and MEDLINE databases.</p><p><strong>Results: </strong>In low risk patients with favorable prognostic factors such as tumor size ≤2 cm, depth of stromal invasion ≤10 mm and no LVSI, there are 5% of patients having positive pelvic lymph nodes. Although parametrial involvement is associated with positive pelvic lymph node metastasis, there are studies which report patients with negative pelvic lymph node involvement with parametrial metastases. This indicates that although negative pelvic lymph nodes in low risk patients is a favorable criterion among of those previously reported for conservative treatment, does not eliminate the possibility of parametrial involvement.</p><p><strong>Conclusions: </strong>Although specific favorable prognostic characteristics may indicate less radical treatment for low risk patients with early stage cervical cancer, more research is needed to estimate the risk of parametrial involvement in low risk patients without pelvic node involvement.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36715965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-grade endometrial stromal sarcoma combined with leiomyoma (stromomyoma): A bizarre tumor of the uterus in a premenopausal woman. 低级别子宫内膜间质肉瘤合并平滑肌瘤:一种发生在绝经前妇女子宫的奇怪肿瘤。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2018-11-01
Okan Yenicesu, Aytekin Tokmak, Ali Levent Sirvan, Nuri Danisman, Tayfun Güngör

Objective: Uterine sarcomas are very rare malignancies, and when a hysterectomy is performed for benign causes, a risk of about 1/500 is mentioned for possible uterine sarcomas. Endometrial stromal neoplasms are a rare subgroup of uterine sarcomas that account for less than 10% of all uterine sarcomas. Mixed endometrial stromal and smooth muscle tumors, also known as stromomyomas, are defined as having at least 30% each of endometrial stromal and smooth muscle components. As a result, stromomyoma is an extremely rare malignant mixed mesenchymal tumor of the uterus. Both clinically and histologically, the differential diagnosis is challenging. Stromomyoma should be kept in mind in the differential diagnosis of large uterine masses, even if these masses are seen in an asymptomatic woman of reproductive age. In this study, we aimed to present this bizarre tumor of the uterus detected in a premenopausal woman.

目的:子宫肉瘤是一种非常罕见的恶性肿瘤,当因良性原因行子宫切除术时,可能发生子宫肉瘤的风险约为1/500。子宫内膜间质肿瘤是一种罕见的子宫肉瘤亚群,占所有子宫肉瘤的不到10%。混合子宫内膜间质和平滑肌肿瘤,也称为间质瘤,定义为子宫内膜间质和平滑肌成分各占30%以上。因此,间质瘤是一种极为罕见的子宫混合间质恶性肿瘤。无论是临床还是组织学,鉴别诊断都是具有挑战性的。在鉴别诊断大型子宫肿块时应注意间质瘤,即使这些肿块出现在无症状的育龄妇女身上。在这项研究中,我们的目的是提出这种奇怪的子宫肿瘤检测在绝经前妇女。
{"title":"Low-grade endometrial stromal sarcoma combined with leiomyoma (stromomyoma): A bizarre tumor of the uterus in a premenopausal woman.","authors":"Okan Yenicesu,&nbsp;Aytekin Tokmak,&nbsp;Ali Levent Sirvan,&nbsp;Nuri Danisman,&nbsp;Tayfun Güngör","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Uterine sarcomas are very rare malignancies, and when a hysterectomy is performed for benign causes, a risk of about 1/500 is mentioned for possible uterine sarcomas. Endometrial stromal neoplasms are a rare subgroup of uterine sarcomas that account for less than 10% of all uterine sarcomas. Mixed endometrial stromal and smooth muscle tumors, also known as stromomyomas, are defined as having at least 30% each of endometrial stromal and smooth muscle components. As a result, stromomyoma is an extremely rare malignant mixed mesenchymal tumor of the uterus. Both clinically and histologically, the differential diagnosis is challenging. Stromomyoma should be kept in mind in the differential diagnosis of large uterine masses, even if these masses are seen in an asymptomatic woman of reproductive age. In this study, we aimed to present this bizarre tumor of the uterus detected in a premenopausal woman.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36715856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ephrin type-B receptor 4 is an essential mediator in drug-resistance of acute myeloid leukemia cells to Adriamycin. Ephrin b型受体4是急性髓性白血病细胞对阿霉素耐药的重要介质。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2018-11-01
Yang Fu, Xinsheng Gao, Xiaohong Yu, Xiaoli Liu, Qingfeng Du

Objective: Ephrin type-B receptor 4 (EphB4) plays an important role in human carcinogenesis. This study investigated the effects of EphB4 expression in drug-resistance of acute myeloid leukemia cells to Adriamycin using myeloid leukemia cell lines with different degrees of differentiation, including an Adriamycin-resistant HL60 cell line as a model. The data showed that the EphB4 protein was differentially expressed in these myeloid leukemia cell lines, which expression was associated with sensitivity of myeloid leukemia cells to Adriamycin treatment in vitro. Furthermore, EphB4 protein stimulated by EphrinB2-Fc sensitized HL60/ADM cells to Adriamycin in a dose-dependent manner. Specifically, pre-incubation of HL60/ADM with 4 µg/ml EphrinB2-Fc protein for 30 min significantly sensitized tumor cell to Adriamycin treatment by reduction of tumor cell viability and induction of apoptosis (p<0.001), while there was no significant change in other groups (p>0.05). These data provided a proof-of-principle for further development of the EphB4-based strategy for treatment of drug-resistant leukemia.

目的:Ephrin b型受体4 (EphB4)在人类癌变过程中起重要作用。本研究以阿霉素耐药的HL60细胞为模型,以不同分化程度的髓系白血病细胞系为研究对象,探讨EphB4表达在急性髓系白血病阿霉素耐药中的作用。数据显示,EphB4蛋白在这些髓系白血病细胞系中存在差异表达,其表达与体外培养的髓系白血病细胞对阿霉素的敏感性有关。此外,EphrinB2-Fc刺激的EphB4蛋白使HL60/ADM细胞对阿霉素呈剂量依赖性致敏。其中,4µg/ml EphrinB2-Fc蛋白预处理HL60/ADM 30 min后,肿瘤细胞对阿霉素的敏感性显著提高,降低肿瘤细胞活力,诱导凋亡(p0.05)。这些数据为进一步开发基于ephb4的耐药白血病治疗策略提供了原理证明。
{"title":"Ephrin type-B receptor 4 is an essential mediator in drug-resistance of acute myeloid leukemia cells to Adriamycin.","authors":"Yang Fu,&nbsp;Xinsheng Gao,&nbsp;Xiaohong Yu,&nbsp;Xiaoli Liu,&nbsp;Qingfeng Du","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Ephrin type-B receptor 4 (EphB4) plays an important role in human carcinogenesis. This study investigated the effects of EphB4 expression in drug-resistance of acute myeloid leukemia cells to Adriamycin using myeloid leukemia cell lines with different degrees of differentiation, including an Adriamycin-resistant HL60 cell line as a model. The data showed that the EphB4 protein was differentially expressed in these myeloid leukemia cell lines, which expression was associated with sensitivity of myeloid leukemia cells to Adriamycin treatment in vitro. Furthermore, EphB4 protein stimulated by EphrinB2-Fc sensitized HL60/ADM cells to Adriamycin in a dose-dependent manner. Specifically, pre-incubation of HL60/ADM with 4 µg/ml EphrinB2-Fc protein for 30 min significantly sensitized tumor cell to Adriamycin treatment by reduction of tumor cell viability and induction of apoptosis (p<0.001), while there was no significant change in other groups (p>0.05). These data provided a proof-of-principle for further development of the EphB4-based strategy for treatment of drug-resistant leukemia.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36715964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Experimental Therapeutics and Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1